Vespa Capital is pleased to announce that its investment in Chase Search and Selection Limited successfully completed in July 2016.
Chase provides contract sales organisation (CSO) solutions, including the provision of specialist Sales, Nursing and Marketing personnel, to Pharmaceutical, Biotech and Healthcare customers across the UK in addition to permanent recruitment services.
The business is able to leverage its unique, synergistic business model to source high quality personnel quickly, delivering bespoke solutions for customers.
Chase currently deploy over 250 CSO personnel and have well established senior level relationships with the majority of the world’s leading pharmaceutical companies.
Bank debt has been provided by HSBC, whilst Clearwater International, Grant Thornton and CIL all provided advisory services.
“Vespa Capital is a business which holds similar beliefs, business practices and ethics to Chase. The investment by Vespa Capital has enabled Chase to incentivise key personnel moving forward and will allow us to accelerate our growth by investing in adjacent products and services. Additionally, Chase will maintain its current quality offering which differentiates us from other CSOs.”
Chris Phillips, CEO, Chase Search and Selection
"Chase has established a well-deserved reputation in the market for efficiently delivering high quality candidates to their customers, and it is clear that the business has a can-do attitude with high levels of ethics and integrity. We are delighted to be able to back an extremely strong existing management team, which includes impressive operators in Graham Hawthorn and Emma Busby.”
Matt Lyons, Partner, Vespa Capital